Viasonix is an international leader in providing advanced vascular systems. Viasonix 3 main product families include the Falcon product line for peripheral vascular diagnosis (PVD), the Dolphin product line for advanced Transcranial Doppler (TCD) measurements, and the LiteWalk Deep Vein Thrombosis (DVT) prophylaxis systems. The Falcon and Dolphin product families are already successfully distributed internationally in 5 continents. The LiteWalk is a breakthrough system for preventing DVT problems for the home environment. Viasonix is ISO 13485 approved, and its’ products are cleared for sale by the FDA, CE, Health Canada, TGA, AMAR, TFDA, ANVISA, INVIMA, CFDA, KFDA, and many other national regulatory agencies. Viasonix management is extremely experienced and dedicated, leading many products to success in the marketplace over the past few decades.
Falcon is considered a world leader in peripheral vascular diagnostics. It is based on advanced Doppler, pneumatic, and photoplethysmography (PPG) technology, for complete assessment of the vascular circulation. Applications include measurements of Ankle-Brachial index (ABI), segmental blood pressure, and much more.
Dolphin is the most up to date TCD system, designed as a significant upgrade to other TCD systems in the market, such as the Sonara. It is based on high resolution digital Doppler technology, and includes everything everything that you may expect from the most advanced TCD system in the market – and much more.
LiteWalk is an unique solution for large populations with lower limb venous flow disorders. Based on physiologic concepts, it is designed as an extremely comfortable and simple to use home care solution.